Cargando…
BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
INTRODUCTION: B‐cell lymphoma/leukemia 11B (BCL11B) is a subunit of SWI/SNF chromatin remodeling complexes and functions in cell cycle regulation and apoptosis upon DNA replication stress and damages via transcription. Many malignancies were reported to exhibit changes in BCL11B gene expression; how...
Autores principales: | Abe, Hiroyuki, Kamimura, Kenya, Okuda, Shujiro, Watanabe, Yu, Inoue, Jun, Aoyagi, Yutaka, Wakai, Toshifumi, Kominami, Ryo, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417273/ https://www.ncbi.nlm.nih.gov/pubmed/37293953 http://dx.doi.org/10.1002/cam4.6167 |
Ejemplares similares
-
Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers
por: Kamimura, Kenya, et al.
Publicado: (2021) -
Drug-eluting beads in hepatocellular carcinoma
por: Abe, Hiroyuki, et al.
Publicado: (2017) -
Identification of BCL11B as a regulator of adipogenesis
por: Inoue, Jun, et al.
Publicado: (2016) -
Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
por: Honda, Hiroki, et al.
Publicado: (2017) -
HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)